Search clinical trials for: Liver hypertrophy

Total 19001 results

Exai Bio Inc.

Recruiting

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

Cancer

United States
Cytokinetics

Recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM (MAPLE-HCM)

Obstructive Hypertrophic Cardiomyopathy (oHCM)

United States, Denmark, Spain, Netherlands, United Kingdom, Germany, France, China, Israel, Italy, Hungary, Canada
M.D. Anderson Cancer Center
Sirtex Medical

Recruiting

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

Metastases

United States
Karolinska Institutet

Recruiting

Ultrasound Guided Microwave Ablation of Splenomegaly in Children

Portal Hypertension | Splenomegaly; Congestive, Chronic | Panhematopenia; Splenic

Sweden
Universitätsklinikum Köln
Sirtex Technology Pty LTD, Australia

Recruiting

European SIR-Spheres Surgical Registry (ESSURE)

Hepatectomy

Germany
University Hospital, Montpellier
Federation Francophone de Cancerologie Digestive

Recruiting

Simultaneous Portal and Hepatic Vein Versus Portal Vein Embolizations for Hypertrophy of the Future Liver Remnant (HYPER-LIV01)

Liver Metastasis Colon Cancer

France
William Shomali
Incyte Corporation

Recruiting

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Eosinophilia | Hypereosinophilic Syndrome | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Splenomegaly | Hepatomegaly | Chronic Eosinophilic Leukemia, Not Otherwise Specified | JAK2 Gene Mutation | BCR-JAK2 Fusion Protein Expression | Blasts 20 Percent or Less of Peripheral Blood White... and other conditions

United States
Shuguo Zheng, MD

Recruiting

Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

Liver Tumor

China
Sanford Health
National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaborators

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

Mitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditions

United States, Australia
Cytokinetics

Enrolling by invitation

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM (FOREST-HCM)

Symptomatic Hypertrophic Cardiomyopathy (HCM)

United States, France, Israel, Spain, United Kingdom, Italy, Portugal, Poland, Hungary, Denmark, Netherlands, Germany, Czechia
Cytokinetics
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.

Completed

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM (SEQUOIA-HCM) (SEQUOIA-HCM)

Obstructive Hypertrophic Cardiomyopathy (oHCM)

United States, France, Spain, Portugal, Germany, China, United Kingdom, Israel, Netherlands, Denmark, Czechia, Hungary, Italy, Poland
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Nausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary Amyloidosis

United States
Manchester University NHS Foundation Trust
University of Oxford; University of Liverpool; University of Manchester; National... and other collaborators

Active, not recruiting

The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy (TEMPEST)

Hypertrophic Cardiomyopathy

United Kingdom
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Gaucher Disease: BioGaucher (BioGaucher) (BioGaucher)

Splenomegaly | Hepatomegaly

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Farber Disease (BioFarber) (BioFarber)

Splenomegaly | Hepatomegaly | Ceramidase Deficiency | Farber's Lipogranulomatosis

Germany, India, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Sly Disease (MPS VII) (BioSly) (BioSly)

Developmental Delay | Splenomegaly | Hepatomegaly | Skeletal Abnormalities

Germany, India, Sri Lanka, Egypt
Linkoeping University
Karolinska Institutet; Skane University Hospital

Completed

Comparison of N-butyl-cyanoacrylate and Micro Parti-cles Effect in Inducing Liver Hypertrophy After PVE

Portal Vein Embolization, Liver, Hypertrophy

Sweden
Liverpool Hope University

Unknown

Exercise and Nutrition Interventions in Age-related Sarcopenia

Sarcopenia | Muscular Atrophy

United Kingdom
Eastern Hepatobiliary Surgery Hospital

Unknown

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Hepatocellular Carcinoma | Cholangiocarcinoma, Perihilar | Portal Vein Occlusion | Liver; Hypertrophy, Acute

China
University Hospital, Montpellier

Completed

Segment IV Hypertrophy After Liver Venous Deprivation

Major Hepatectomy

France
The George Institute
National Health and Medical Research Council, Australia; Baxter Healthcare...

Completed

A Clinical Trial of IntensiVE Dialysis (ACTIVE)

End Stage Renal Disease | Renal Replacement Therapy | End Stage Kidney Disease | Renal Dialysis | Uremia

New Zealand, Canada, Australia, China
Imperial College London

Completed

Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH) (REBIRTH)

Cancer | Liver Resection

United Kingdom
Hospital Italiano de Buenos Aires

Completed

ALPPS: Safety, Feasibility and Efficacy at a Single Center

Locally Advanced Malignant Liver Disease

Argentina
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis

Primary Myelofibrosis | Splenomegaly | Hepatomegaly | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential Thrombocythemia

United States
Assiut University

Unknown

Prevalence of Hepatomegaly in Children and Adolescents With Type 1 Diabetes Mellitus

Hepatomegaly

Egypt
Washington University School of Medicine

Terminated

4D Phase Contrast MR: Hypertrophy in Liver Cancer

Liver Cancer | Cancer of the Liver

United States
Singapore General Hospital

Unknown

Prospective Post Y90 Liver Hypertrophy

Hepatocellular Carcinoma | Liver Hypertrophy

Singapore
Assistance Publique - Hôpitaux de Paris

Unknown

Cardiac Steatosis in Cushing's Syndrome (CORTICOEUR)

Endocrine System Disease | Cardiovascular Imaging

France
Bio-Medical Research, Ltd.
Liverpool University Hospitals NHS Foundation Trust

Completed

Effects of Kneehab 12-week Peri-operative Total Knee Arthroplasty (KneehabTKA)

Knee Osteoarthritis | Disuse Atrophy

United Kingdom
AbbVie (prior sponsor, Abbott)
Massachusetts General Hospital

Completed

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4 (PRIMO)

Chronic Kidney Disease | Left Ventricular Hypertrophy

United States, Australia, Czech Republic, Germany, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom
Mayo Clinic
Novartis; National Center for Research Resources (NCRR)

Completed

Octreotide in Severe Polycystic Liver Disease

Liver Diseases | Abdominal Pain | Polycystic Kidney, Autosomal Dominant | Hepatomegaly | Polycystic Liver Disease | Kidney, Polycystic

United States
Abbott
Massachusetts General Hospital; Harvard University

Terminated

The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 (PRIMO II)

Hypertrophy, Left Ventricular | Chronic Kidney Disease (CKD) Stage 5

Italy, United States, Taiwan, Poland, United Kingdom, Greece, Germany, Russian Federation, Spain, Australia, Czech Republic, Puerto Rico, Romania
AEterna Zentaris

Completed

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) (AEZS-102-Z041)

Benign Prostatic Hypertrophy

United States, Canada
Xijing Hospital
Air Force Military Medical University, China; Health Science Center of Xi'an...

Unknown

Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis

Liver Cirrhosis | Carcinoma, Hepatocellular | Laparotomy | Splenomegaly

China
Radboud University Medical Center
Ipsen

Completed

Lanreotide as Treatment of Polycystic Livers (LOCKCYST)

Liver Diseases | Polycystic Kidney, Autosomal Dominant | Hepatomegaly | Polycystic Liver Disease

Netherlands, Belgium
Radboud University Medical Center
Ipsen

Unknown

Open-Label Extension of LOCKCYST Trial (LOCKCYST-ext)

Liver Diseases | Hepatomegaly | Polycystic Liver Disease | Polycystic Kidney | Autosomal Dominant

Netherlands, Belgium
Hunter Holmes Mcguire Veteran Affairs Medical Center

Recruiting

Microbiome Modulation With Prebiotics in PTSD and Cirrhosis (RESIST-PTSD)

PTSD | Cirrhosis

United States
Ain Shams University
Mohamed, Ahmed A., M.D.; Amr Amin Biology Department, UAE University, Al Ain... and other collaborators

Not yet recruiting

Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma

Hepatocellular Carcinoma

Egypt
Asociación Colombiana de Hepatología

Recruiting

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia (HCV-PIWD)

Hepatitis C Virus Infection

Colombia
Merck Sharp & Dohme LLC

Not yet recruiting

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Non-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Steatohepatitis | Metabolic Dysfunction-associated Steatotic Liver Disease | Metabolic Dysfunction-associated Steatohepatitis
Beijing 302 Hospital

Not yet recruiting

Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Shengjing Hospital

Recruiting

Multifrequency MRE for Assessing Chronic Hepatic Disease

Liver Stiffness

China
Zhejiang University
Carbiogene Therapeutics Co. Ltd.

Not yet recruiting

Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
American Heart Association

Not yet recruiting

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform (HCM FLIP)

Hypertrophic Cardiomyopathy
Chinese PLA General Hospital

Recruiting

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma (MALRIC)

Overall Survival | Disease-free Survival

China
Sahlgrenska University Hospital, Sweden

Not yet recruiting

HIBOC = Hepatic Imaging Biomarkers in Obese Children

Fibrosis, Liver | Steatosis | Elastography | Diagnosis | Child Obesity | Metabolic Disease | Shear Wave Elastography | Shear Wave Dispersion | Attenuation Imaging | Metabolic and Genetic Disorder Affecting the Liver | Inflammation; Liver
Institute of Liver and Biliary Sciences, India

Not yet recruiting

To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics

Critically Ill Cirrhotics

India
University of Pittsburgh
Patient-Centered Outcomes Research Institute

Not yet recruiting

Getting To Implementation: Improving Cancer Screening for Veterans (GTI)

Cirrhosis | Cancer of Liver | Cancer of Colon

United States
Institute of Medical Biology, Chinese Academy of...

Not yet recruiting

Phase IV Study of Concomitant Administration of the sIPV and HepA

Hepatitis A | Polio

China
King's College London
King's College Hospital NHS Trust; Imperial College London; Guy's and St Thomas... and other collaborators

Recruiting

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis (PROMISE)

Liver Cirrhosis

United Kingdom

Search clinical trials for: Liver hypertrophy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations